SCHEMBL15973283

SCHEMBL15973283

COc1ccc(CN2C(=O)NC(C)(c3ccccc3OC)C2=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.51
KDM4E B2RXH2 1/20 0.49
HTT P42858 1/20 0.49
ALDH1A1 P00352 3/20 0.48
MAPK1 P28482 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 1/20 0.48
CMA1 P23946 1/20 0.48
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
HDAC6 Q9UBN7 2/20 0.46
GSK3A P49840 1/20 0.46
GSK3B P49841 1/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
CASP3 P42574 1/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
HTR1A P08908 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1773322 0.77 CMA1 (0.60) KDM4EHTTALDH1A1MAPK1SMN1; SMN2
SCHEMBL15974814 0.77 CMA1 (0.50) SCN9AKDM4EALDH1A1LMNACMA1
SCHEMBL16109588 0.77 SCN9A (0.56) SCN9ALMNACMA1CYP3A4CYP2C19
SCHEMBL14501653 0.76 SCN9A (0.55) SCN9AKDM4EHTTALDH1A1LMNA
SCHEMBL2065684 0.76 ALDH1A1 (0.56) KDM4EHTTALDH1A1MAPK1SMN1; SMN2
SCHEMBL15974624 0.75 CYP3A4 (0.64) MAPK1CYP3A4CYP2C19TP53MEN1
SCHEMBL17377477 0.73 SCN9A (0.63) SCN9ASMN1; SMN2LMNACMA1GSK3A
SCHEMBL9540132 0.72 SCN9A (0.54) SCN9AKDM4EHTTALDH1A1LMNA
SCHEMBL9539012 0.71 OPRL1 (0.51) SCN9AALDH1A1LMNACMA1GSK3A
SCHEMBL25430199 0.71 SCN9A (0.65) SCN9ASMN1; SMN2LMNACMA1GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11028052-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2021-06-08 US disclosed
EP-3461816-B1 FIVE-MEMBERED HETEROCYLIC COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED (US) 2021-03-24 EP disclosed
US-10421727-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2019-09-24 US disclosed
EP-3461816-A1 FIVE-MEMBERED HETEROCYLIC COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2019-04-03 EP disclosed
US-20170369447-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED 2017-12-28 US disclosed
US-9840471-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2017-12-12 US disclosed
US-20150376136-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. 2015-12-31 US disclosed
EP-2958897-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2015-12-30 EP disclosed
WO-2014130582-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2014-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10421727-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPA1 SCN9A 91/4885KDM4E 4328/4885HTT 3844/4885
US-20150376136-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPA1 SCN9A 91/4885KDM4E 4328/4885HTT 3844/4885
US-20170369447-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPA1 SCN9A 91/4885KDM4E 4328/4885HTT 3844/4885
US-11028052-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPA1 SCN9A 91/4885KDM4E 4328/4885HTT 3844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.